EP1370138A4 - Therapie genique pour tissus neurologiques - Google Patents

Therapie genique pour tissus neurologiques

Info

Publication number
EP1370138A4
EP1370138A4 EP02713697A EP02713697A EP1370138A4 EP 1370138 A4 EP1370138 A4 EP 1370138A4 EP 02713697 A EP02713697 A EP 02713697A EP 02713697 A EP02713697 A EP 02713697A EP 1370138 A4 EP1370138 A4 EP 1370138A4
Authority
EP
European Patent Office
Prior art keywords
gene therapy
neurological tissues
neurological
tissues
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02713697A
Other languages
German (de)
English (en)
Other versions
EP1370138A1 (fr
Inventor
David P Hesson
Glenn D Frazer
Bruce Shook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuron Therapeutics Inc
Original Assignee
Neuron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics Inc filed Critical Neuron Therapeutics Inc
Publication of EP1370138A1 publication Critical patent/EP1370138A1/fr
Publication of EP1370138A4 publication Critical patent/EP1370138A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP02713697A 2001-03-02 2002-02-28 Therapie genique pour tissus neurologiques Withdrawn EP1370138A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US798775 1997-02-11
US79877501A 2001-03-02 2001-03-02
PCT/US2002/005886 WO2002069711A1 (fr) 2001-03-02 2002-02-28 Therapie genique pour tissus neurologiques

Publications (2)

Publication Number Publication Date
EP1370138A1 EP1370138A1 (fr) 2003-12-17
EP1370138A4 true EP1370138A4 (fr) 2004-08-18

Family

ID=25174236

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02713697A Withdrawn EP1370138A4 (fr) 2001-03-02 2002-02-28 Therapie genique pour tissus neurologiques

Country Status (2)

Country Link
EP (1) EP1370138A4 (fr)
WO (1) WO2002069711A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008115880A2 (fr) * 2007-03-21 2008-09-25 The Board Of Regents Of The University Of Texas System Utilisation de leptine pour le traitement ou la prévention de la maladie de parkinson

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005870A2 (fr) * 2000-07-19 2002-01-24 Neuron Therapeutics, Inc. Kits et compositions pour la realisation d'injections intracraniennes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569180A (en) * 1991-02-14 1996-10-29 Wayne State University Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005870A2 (fr) * 2000-07-19 2002-01-24 Neuron Therapeutics, Inc. Kits et compositions pour la realisation d'injections intracraniennes

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AEBISCHER P ET AL: "Recombinant proteins for neurodegenerative diseases: the delivery issue", TRENDS IN NEUROSCIENCE, ELSEVIER, AMSTERDAM, NL, vol. 24, no. 9, 1 September 2001 (2001-09-01), pages 533 - 540, XP004298585, ISSN: 0166-2236 *
BACHOUD-LEVI A -C ET AL: "Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF", HUMAN GENE THERAPY, vol. 11, no. 12, 10 August 2000 (2000-08-10), pages 1723 - 1729, XP002284732, ISSN: 1043-0342 *
BOSE B ET AL: "Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion.", NEUROSURGERY. UNITED STATES MAR 1986, vol. 18, no. 3, March 1986 (1986-03-01), pages 270 - 276, XP009032314, ISSN: 0148-396X *
ERIKSDOTTER JÖNHAGEN M ET AL: "Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.", DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. SWITZERLAND 1998 SEP-OCT, vol. 9, no. 5, September 1998 (1998-09-01), pages 246 - 257, XP002284731, ISSN: 1420-8008 *
KORDOWER JEFFREY H ET AL: "Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 290, no. 5492, 2000, pages 767 - 773, XP002207711, ISSN: 0036-8075 *
MCINNES RODERICK R ET AL: "Neural stem cells: A versatile tool for cell replacement and gene therapy in the central nervous system", CLINICAL GENETICS, vol. 56, no. 4, October 1999 (1999-10-01), pages 267 - 278, XP002284734, ISSN: 0009-9163 *
See also references of WO02069711A1 *

Also Published As

Publication number Publication date
EP1370138A1 (fr) 2003-12-17
WO2002069711A1 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
IL158618A0 (en) Biological pacemaker
GB0512560D0 (en) Bioreactors for well treatment
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002226650A8 (en) Redox therapy for tumors
IL157944A0 (en) Hormone replacement therapy
GB0118383D0 (en) Therapeutic methods
EP1318822A4 (fr) Therapie d'implantation cellulaire destinee aux troubles ou maladies neurologiques
GB0327384D0 (en) Gene therapy
EP1401494A4 (fr) Traitement anti-tumoral
GB0101933D0 (en) Therapy
GB0108485D0 (en) Combination therapy
EP1370138A4 (fr) Therapie genique pour tissus neurologiques
GB0025890D0 (en) Gene therapy
EP1578908A4 (fr) Gene humain de la schizophrenie
GB9900009D0 (en) Gene therapy
GB0008966D0 (en) Vectors for gene therapy
AU2002245534A1 (en) Gene therapy for neurological tissues
HU0200253D0 (en) Combination therapy
GB0406539D0 (en) Gene therapy
GB2397018B (en) Combination therapy for treating disease
AU2002242293A1 (en) Treatment of neurological disease
EP1426443A4 (fr) Nouveau gene humain bmcc1
EP1387892A4 (fr) Composes de distribution genique
GB2413798B (en) Bioreactors for well treatment
GB0005844D0 (en) Gene therapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030919

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 3/00 B

Ipc: 7A 61P 25/00 B

Ipc: 7A 61P 21/00 B

Ipc: 7A 61K 31/7004 B

Ipc: 7A 61K 48/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040701

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040901